Research progress in the treatment of retinoblastoma

Retinoblastoma(RB)is the most common intraocular malignant tumor in infants, the pathogenesis of which, is related to gene mutations. In order to improve the survival rate and eye-protection rate of RB patients, the therapeutic approaches have been constantly updated and developed, mainly including...

Full description

Bibliographic Details
Main Authors: Hong-Mi Zou, Jia Jian, Xi-Yuan Zhou
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2018-08-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2018/8/201808011.pdf
Description
Summary:Retinoblastoma(RB)is the most common intraocular malignant tumor in infants, the pathogenesis of which, is related to gene mutations. In order to improve the survival rate and eye-protection rate of RB patients, the therapeutic approaches have been constantly updated and developed, mainly including chemotherapy, radiation therapy, surgical treatment, physiotherapy, photochemotherapy, gene therapy at present. In this article, we mainly reviewed the progress of RB treatment.
ISSN:1672-5123
1672-5123